Association Between HPV Circulating Tumor DNA and Prognostic Inflammatory Indices in Oropharyngeal Squamous Cell Carcinoma: A Pilot Study

QR Code

Association Between HPV Circulating Tumor DNA and Prognostic Inflammatory Indices in Oropharyngeal Squamous Cell Carcinoma: A Pilot Study

Abstract Circulating tumor DNA (ctDNA) has been developed as a marker of tumor burden in human papillomavirus (HPV)‐positive oropharyngeal squamous cell carcinoma (OPSCC). Inflammatory indices are also increasingly being used as prognostic surrogate markers in solid tumors, including head and neck c...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ryan S. Ziltzer, Zulkifl I. Jafary, Connor Hunt, Iraj Hasan, Meghan T. Turner
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	OTO Open
Subjects:	circulating tumor DNA head and neck cancer HPV inflammatory indices oropharyngeal squamous cell carcinoma
Online Access:	https://doi.org/10.1002/oto2.70116
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Estimation of the prevalence of HPV-positive squamous cell carcinoma of the oropharynx on the example of a separate sample in the Russian Federation
by: B. G. Pkheshkhova, et al.
Published: (2022-04-01)

Ultrasound diagnosis of oropharyngeal squamous cell carcinoma and ultrasound evaluation of treatment efficacy (changes in tumor volume)
by: G. F. Allakhverdieva, et al.
Published: (2019-10-01)

Preoperative Nodal Biopsy and Extranodal Extension in p16+ Oropharyngeal Squamous Cell Carcinoma
by: Sindhura Sridhar, et al.
Published: (2025-06-01)

Circulating biomarkers in HPV-associated oropharyngeal cancer: Clinical applications of liquid biopsy in diagnosis, prognosis, and surveillance
by: Swati Kumari, et al.
Published: (2025-09-01)

The Impact of Digital Inequities on Oropharyngeal Cancer Disparities in the United States
by: David J. Fei‐Zhang, et al.
Published: (2025-04-01)

Pre-treatment anemia in head and neck cancer: risk factors, subtypes, and survival outcomes
by: Cornelius H. L. Kürten, et al.
Published: (2025-06-01)

The effectiveness of a dual-component regimen of induction chemotherapy in the treatment of HPV-positive oropharyngeal squamous cell carcinoma
by: P. V. Golubev, et al.
Published: (2023-05-01)

Treatment strategy for HPV-positive oropharyngeal cancer: a literature review
by: O. A. Saprina
Published: (2022-08-01)

INDIVIDUAL ORAL HYGIENE QUALITY INFLUENCE ON THE SEVERITY OF POST-RADIATION MUCOSITIS IN PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE OROPHARYNGEAL REGION
by: A. M. Avanesov, et al.
Published: (2020-06-01)

Dental status of patients with squamous cell carcinoma of the oropharyngeal region
by: A. M. Avanesov, et al.
Published: (2019-12-01)

Nutritional support in patients with squamous cell carcinoma of the oropharyngeal area
by: A. M. Mudunov, et al.
Published: (2016-03-01)

Risk factors for head and neck squamous cell carcinoma in disease pathogenesis and prognosis: the importance of smoking cessation and the concept of harm reduction
by: A. I. Stukan, et al.
Published: (2024-04-01)

Neoadjuvant sintilimab and chemotherapy followed by transoral surgery for HPV-positive resectable oropharyngeal cancer: a single-arm, two-centre, phase 2 trialResearch in context
by: Shida Yan, et al.
Published: (2025-08-01)

The results of immunotherapy in patients with recurrent and metastatic human papilloma virus positive head and neck squamous cell carcinoma
by: A. V. Ignatova, et al.
Published: (2024-06-01)

Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma
by: Dietz, Andreas, et al.
Published: (2025-06-01)

No Survival Effect in Cell Lines with Different Growth Factor-Induced Division Rates, but with Different Fractionation Schemes
by: Lena Blanke, et al.
Published: (2025-04-01)

ASSESSMENT OF BLOOD SERUM PROTEOME IN PATIENTS WITH SQUAMOUS CELL HEAD AND NECK CARCINOMA
by: G. V. Kakurina, et al.
Published: (2016-02-01)

Correction of malnutrition in patients with oropharyngeal squamous cell carcinoma
by: A. M. Mudunov, et al.
Published: (2015-11-01)

Prediction of combination therapy efficacy in patients with locally advanced squamous cell oropharyngeal carcinoma
by: I. A. Bakhronov, et al.
Published: (2024-05-01)

Oropharyngeal cancer diagnosis and treatment in actual clinical practice in the Republic of Bashkortostan: analysis for 2020
by: Sh. I. Musin, et al.
Published: (2023-01-01)

SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK: NEW AVENUES OF TREATMENT?
by: T. Braunschweig, et al.
Published: (2015-04-01)

Robotic surgery in the treatment of oropharyngeal cancer: a case report
by: O. A. Saprina, et al.
Published: (2023-11-01)

MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013-03-01)

Definitive treatment in squamous cell carcinoma of head and neck: A retrospective analysis of chemoradiotherapy in a university hospital setting
by: Hádila Silva Veras Sousa, et al.
Published: (2025-07-01)

Molecular and clinical aspects of oropharyngeal squamous cell carcinoma associated with human papillomavirus
by: D. Sh. Polatova, et al.
Published: (2021-08-01)

Methylation of the tumor associated genes in head and neck squamous cell carcinoma
by: S. V. Kurevlev, et al.
Published: (2023-03-01)

Study of head and neck squamous cell carcinoma transcriptome after proton therapy
by: E. D. Jumaniyazova, et al.
Published: (2024-04-01)

Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma
by: A. I. Stukan, et al.
Published: (2020-04-01)

Radiodosiomics Prediction of Treatment Failures Prior to Chemoradiotherapy in Head-and-Neck Squamous Cell Carcinoma
by: Hidemi Kamezawa, et al.
Published: (2025-06-01)

Prognostic significance of systemic inflammatory markers in oropharyngeal squamous cell carcinoma
by: Jan Horackiewicz, et al.
Published: (2025-09-01)

Prevalence of HPV/p16+ infection among oropharyngeal squamous cell carcinoma patients in a tertiary care centre in Southern India
by: V. Jawahar, et al.
Published: (2023-10-01)

Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors
by: A. I. Stukan', et al.
Published: (2018-11-01)

Matrix metalloproteinase system in blood serum in patients with squamous cell head and neck carcinomas
by: Ye. V. Klisho, et al.
Published: (2011-02-01)

Successful treatment of recurrent unresectable squamous cell carcinoma of the head and neck using pembrolizumab
by: A. M. Mudunov, et al.
Published: (2019-04-01)

THE MANDIBULAR PERIOSTEUM AS A METASTATIC SITE FOR OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
by: D. V. Sikorsky, et al.
Published: (2015-04-01)

Pembrolizumab in treatment of head and neck squamous cell carcinoma: clinical cases and real-world practice
by: Yu. V. Alymov, et al.
Published: (2023-09-01)

Chemotherapy with cetuximab in head and neck squamous cell carcinoma: immunological aspects and markers of treatment effectiveness in clinical practice
by: A. I. Stukan, et al.
Published: (2024-06-01)

HEAD AND NECK SQUAMOUS CELL CARCINOMA DEPENDING ON THE MORPHOLOGICAL CHARACTERISTICS OF THE PRIMARY TUMOR
by: V. A. Bychkov, et al.
Published: (2017-06-01)

Evaluation of Clinical and Hematological Inflammatory Profile in Patients Treated for Oral Squamous Cell Carcinoma - A Prospective Cohort Study
by: G Chenchulakshmi, et al.
Published: (2025-04-01)

Molecular and genetic profile of head and neck squamous cell carcinoma
by: A. I. Stukan, et al.
Published: (2018-10-01)